Journals / Turkish archives of pediatrics (Online) / 2022 / Cilt: 57 - Sayı: 4

Gastrointestinal and Liver Manifestations in Children with COVID-19 and Their Relationship to Clinical Course

Pages
413–420
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Conclusion: The presence of gastrointestinal symptoms or elevated liver enzymes does not affect the course of the disease in children with coronavirus disease 2019.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: Coronavirus disease 2019 is a major health problem in all age groups.
📊
Key Findings & Data:In this study, we evaluated the frequencies of gastrointestinal symptoms and liver biochemical findings in children with coronavirus disease 2019 and their relationship with clinical course and length of hospital stay.
💡
Conclusion & Impact:Conclusion: The presence of gastrointestinal symptoms or elevated liver enzymes does not affect the course of the disease in children with coronavirus disease 2019.
🔬Design:Research Article
📍Scope:2019 Verileri
⚙️Variables:Domain Parameters

Özet

Objective: Coronavirus disease 2019 is a major health problem in all age groups. Although most clinical symptoms are respiratory, gastrointestinal symptoms are often reported. This is a major concern for children and has limited research coverage. In this study, we evaluated the frequencies of gastrointestinal symptoms and liver biochemical findings in children with coronavirus disease 2019 and their relationship with clinical course and length of hospital stay. Materials and Methods: Demographic data, clinical, and laboratory findings of children with Coronavirus disease 2019 who were followed up by the Department of Pediatric Infectious Diseases between March 2020 and August 2020 were recorded. They were classified according to age groups as 10 years. Laboratory findings were analyzed according to age groups. Demographic, clinical, and laboratory findings were compared in both situations, the presence of gastrointestinal symptoms and the presence of elevated liver enzymes. It was considered statistically significant if it was <.05. Results: A total of 294 patients (median age 10 years [14 days to 18 years]) were enrolled in this study. Although fever is the most common symptom of coronavirus disease 2019, 15.6% of patients presented with acute gastroenteritis. Most patients with liver involvement (n = 130, 44.2%) were under 5 years of age (n = 74, 56.9%, P < .001). The patterns of abnormal liver test results were cholestatic (71.5%), hepatocellular (18.4%), and mixed (10%) types. Severe or massive elevation of aminotransferase or liver failure was not observed. No statistically significant difference was noted in outcomes, including length of stay, for patients with gastrointestinal symptoms (P = .178) or liver involvement (P = .146). Conclusion: The presence of gastrointestinal symptoms or elevated liver enzymes does not affect the course of the disease in children with coronavirus disease 2019.

🔖

Cite This Article

ALKAN, G., EMİROĞLU, M., ÖZ, Ş. K. T., EMİROĞLU, H. H., DAĞI, H., KÖREZ, K. (2022). Gastrointestinal and Liver Manifestations in Children with COVID-19 and Their Relationship to Clinical Course. Turkish archives of pediatrics (Online), Cilt: 57 - Sayı: 4, 413–420. https://ajindex.com/articles/418294

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (14)

  1. Molloy EJ, Bearer CF. COVID-19 in children and altered inflammatory responses [internet]. Pediatr Res. 2020
  2. 88(3):340-341. [CrossRef] 2. Ramachandran P, Onukogu I, Ghanta S, et al. Gastrointestinal symptoms and outcomes in hospitalized coronavirus disease 2019 patients. Dig Dis. 2020
  3. 38(5):373-379. [CrossRef] 3. Pousa PA, Mendonça TSC, Oliveira EA, Simões-e-Silva AC. Extrapulmonary manifestations of COVID-19 in children: a comprehensive review and pathophysiological considerations [internet]. J Pediatr (Rio J). 2021
  4. 97(2):116-139. [CrossRef] 4. Donà D, Minotti C, Costenaro P, Da Dalt L, Giaquinto C. Fecal-oral transmission of SARS-CoV-2 in children: is it time to change our approach? Pediatr Infect Dis J. 2020
  5. 39(7):e133-e134. [CrossRef] 5. Balasubramanian S, Rao NM, Goenka A, Roderick M, Ramanan AV. Coronavirus disease 2019 (COVID-19) in children - what we know so far and what we do not. Indian Pediatr. 2020
  6. 57(5):435-442. [CrossRef] 6. Esmaeili Dooki ME, Mehrabani S, Sorkhi H, et al. COVID-19 and digestive system in children: a retrospective study. Arch Iran Med. 2020
  7. 23(11):782-786. [CrossRef] 7. Wu J, Song S, Cao HC, Li LJ. Liver diseases in COVID-19: etiology, treatment and prognosis [internet]. World J Gastroenterol. 2020
  8. 26(19):2286-2293. [CrossRef] 8. Negro F. Is antibody-dependent enhancement playing a role in COVID-19 pathogenesis? Swiss Med Wkly. 2020
  9. w20249. [CrossRef] 9. Chu H, Chan JF-W, Yuen TT-T, et al. Comparative tropism, replication kinetics, and cell damage profiling of SARS-CoV-2 and SARSCoV with implications for clinical manifestations, transmissibility, and laboratory studies of COVID-19: an observational study. Lancet Microbe. 2020
  10. 1(1):e14-e23. [CrossRef] 10. Matthai J, Shanmugam N, Sobhan P, Indian Society of Pediatric Gastroenterology, Hepatology and Nutrition
  11. Pediatric Gastroenterology Chapter of Indian Academy of Pediatrics. Coronavirus disease (COVID-19) and the gastrointestinal system in children. Indian Pediatr. 2020
  12. 57(6):533-535. [CrossRef] 11. Puoti MG, Rybak A, Kiparissi F, Gaynor E, Borrelli O. SARS-CoV-2 and the gastrointestinal tract in children. Front Pediatr. 2021
  13. 617980. [CrossRef] 12. European Association for the Study of the Liver. EASL Clinical Practice Guidelines: Management of cholestatic liver diseases. J Hepatol. 2009
  14. 51(2):237-267. [CrossRef] 13. Roussel Uclaf Causality Assessment Method (RUCAM) in Drug Induced Liver Injury [internet]. LiverTox: Clinical and Research Information on Drug-Induced Li